Login / Signup

Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?

Amr AhmedMahmoud El KazzazAml M Brakat
Published in: Advanced pharmaceutical bulletin (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • type diabetes
  • mild cognitive impairment
  • glycemic control
  • white matter
  • respiratory syndrome coronavirus
  • skeletal muscle
  • adipose tissue